Biotech Manufacturing Strategy & Outsourcing Advisory

Your Science Is Ready.
Your Manufacturing Strategy
Shouldn’t Be Guesswork.

Choosing the wrong CDMO, missing a tech transfer milestone, or building the wrong outsourcing model can set your program back by years. 3Kinnect Solutions brings the operational and strategic expertise you need to move faster with confidence.

15+
Years in Biotech & CMC Operations
PhD
Chemistry · Cancer Research
ADC
Biologics & Antibody-Drug Conjugate Expertise

The Manufacturing Gap
Is Killing Biotech Timelines

Emerging biotech teams build breakthrough science, then hit a wall when it comes to manufacturing execution. These are the breakdowns we see — and solve — every day.

CDMO Selection Is Taking Months — and Still Feels Like a Gamble

Without a structured evaluation process, RFPs go out without the right criteria, vendor visits reveal nothing useful, and you end up choosing on cost over fit.

Your Tech Transfer Is Stalled and No One Owns the Problem

Misaligned expectations, underdefined scopes, and no operational oversight turn tech transfer into a black hole — consuming budget and runway without progress.

Lean Teams Are Stretched Across Science, Operations, and Regulatory

Virtual biotechs and startups don't have a dedicated CMC or MSAT team. Manufacturing decisions get made reactively — and often wrong — when headcount can't keep up.

Your Outsourcing Model Doesn't Scale With Your Pipeline

A single CDMO relationship might work for Phase 1, but commercial-scale strategy requires a manufacturing network built for redundancy, capacity, and future flexibility.

RFI/RFP Processes Are Inconsistent and Not Fit for Purpose

Generic templates don't capture what matters for biologics or ADCs. Without the right technical and operational questions, vendor proposals are impossible to compare meaningfully.

Investor Scrutiny of Your CMC Strategy Is Increasing

As you move toward IND filing or Series B, sophisticated investors want to see a credible, de-risked manufacturing plan — not a CDMO name dropped into a deck slide.

Strategic Clarity.
Operational Execution.
Measurable Results.

We don't hand you a framework and walk away. We work alongside your team to solve real manufacturing and outsourcing challenges — from day one through CDMO onboarding and beyond.

Structured CDMO selection — not guesswork

Objective evaluation frameworks, scoring criteria built for your modality, and independent due diligence.

Accelerated tech transfer and onboarding

Defined milestones, clear accountability, and the technical oversight to keep projects on track.

Investor-ready CMC and outsourcing strategy

A defensible manufacturing narrative that holds up in due diligence — from Seed through Series C.

Embedded operational expertise on demand

Fractional MSAT and CMC support for lean teams — without the cost or commitment of a full-time hire.

If this is your situation — here's what you get:
If

You're shortlisting CDMOs for a biologic or ADC program and need an objective evaluation process

You Get

A structured RFP process, customized scorecard, site visit protocols, and a selection recommendation backed by technical rigor

If

You're a virtual biotech with no internal CMC team and a CDMO relationship that's drifting

You Get

Fractional MSAT support, vendor governance frameworks, and the operational oversight to keep your program moving

If

You're scaling from Phase 1 to Phase 2/3 and need to build a manufacturing network strategy

You Get

A multi-CDMO network assessment, risk stratification, commercial readiness roadmap, and capacity planning guidance

End-to-End External
Manufacturing Strategy

From CDMO identification to commercial manufacturing readiness — every engagement is designed to reduce risk, accelerate timelines, and give your team the operational confidence to execute.

01

CDMO Selection & Evaluation

Structured identification, RFI/RFP development, technical due diligence, site visits, and objective vendor scoring for biologics and ADC programs.

RFI / RFPDue DiligenceSite Assessment
02

Tech Transfer & CDMO Onboarding

End-to-end transfer planning, milestone tracking, cross-functional coordination, and hands-on oversight to ensure a seamless transition to your manufacturing partner.

Transfer PlanningMilestone MgmtRisk Mitigation
03

External MSAT & CMC Advisory

Fractional manufacturing sciences and technology support — for lean teams who need embedded operational expertise without the full-time headcount.

Fractional MSATCMC StrategyBiologics
04

Manufacturing Network Strategy

Single-to-multi-CDMO network design, geographic and capacity risk assessment, commercial scale planning, and long-term supply chain resilience strategy.

Network DesignCapacity PlanningCommercial Scale
05

Outsourcing Strategy & Risk Assessment

Build-vs-buy analysis, outsourcing model design, vendor risk stratification, and governance frameworks that keep your external manufacturing relationships aligned.

Build vs BuyVendor GovernanceRisk Scoring
06

Program Management for Outsourced Development

Cross-functional program management for outsourced development — from IND-enabling studies through commercial manufacturing readiness.

Program MgmtADC ProgramsExecution

Built for Speed.
Designed for Your Program.

1

Discovery Call

We map your program stage, manufacturing challenges, and outsourcing goals in a focused 30-minute conversation.

2

Strategy Brief

We define scope, deliverables, and a customized engagement model — from project-based to fractional advisory.

3

Execution

We work alongside your team to deliver structured, actionable outputs — not slides that collect dust.

4

Ongoing Support

Retained advisory, vendor oversight, and embedded support to keep your manufacturing strategy on track through scale-up.

Dr. Tamika Drummond

Dr. Tamika Drummond

PhD · Founder & Principal Consultant

Science Fluency.
Operational Depth.
Strategic Clarity.

Dr. Drummond founded 3Kinnect Solutions to close the gap between breakthrough science and real-world manufacturing execution. With a PhD in Chemistry and a career built on leading CDMO selection initiatives, building outsourcing strategies for biotech programs, and managing complex external manufacturing relationships, Dr. Drummond brings a rare combination of scientific rigor and operational experience to every engagement.

Her background spans years of cancer research and hands-on work in CMC operations — giving her a first-hand understanding of what it takes to move a molecule from lab bench to manufacturing at scale. She has worked with virtual biotechs, emerging pharma, and development-stage companies navigating the full outsourcing lifecycle for biologics and antibody-drug conjugates.

PhD, Chemistry
Cancer Research Background
Biologics & ADC Manufacturing
Cross-Functional CMC Leadership
CDMO Selection & Evaluation Expert
15+
Years in biotech, CMC & manufacturing operations
ADC +
mAb
Deep modality expertise across biologics & conjugates
End-to-end
From CDMO selection through commercial scale strategy
Virtual
First
Built for lean teams without internal CMC infrastructure

Ready to Build a Smarter Manufacturing Strategy?

Whether you're at the start of your CDMO search, in the middle of a stalled tech transfer, or building out your outsourcing model for scale — let's find out if we're the right fit for your program.

30-minute complimentary strategy consultation — no obligation
Project-based, advisory retainer, or fractional engagement models available
Engagements designed for emerging biotech timelines and budgets
Immediate availability for critical-path CDMO and CMC challenges
"The question isn't whether you can afford external manufacturing expertise — it's whether you can afford the cost of getting it wrong."
— Dr. Drummond, Founder, 3Kinnect Solutions
Start the Conversation
Fill out the form below and we'll be in touch within one business day.

Your information is kept strictly confidential and will never be shared.